Timothy Corn

Dr. Timothy H.
Corn, MD, is an Executive Director & Chief Medical Officer at Oxford Cannabinoid Technologies Holdings Plc, a Chairman at Neuro Foundation and a Chief Medical Officer at Nodenza, Inc. He is on the Board of Directors at Oxford Cannabinoid Technologies Holdings Plc and Nerve Tumours Uk.
Dr. Corn was previously employed as an Independent Non-Executive Director by Physiomics Plc, a Chief Medical Officer by Izana Bioscience Ltd., an Independent Non-Executive Director by HRA Pharma Development SARL, an Independent Non-Executive Director by ReNeuron Group Plc, an Independent Non-Executive Director by Circassia Group Plc, a Non-Executive Director by NIOX Healthcare Ltd., a Chief Medical Officer by Zeneus Pharma Ltd., a Principal by Athena Neurosciences LLC, a Principal by Elan Corp.
Plc, a Chief Medical Officer by Eusa Pharma International Ltd., a Chief Medical Officer by EUSA Pharma, Inc., a Chief Medical Officer by Jazz Pharmaceuticals UK Ltd., a Non-Executive Director by Neurocentrx Pharma Ltd., and a Principal by Organon Pharma (UK) Ltd. He received his graduate degree from Imperial College London and a doctorate degree from King's College London.